Androgen receptor modulators and uses thereof

Details for Australian Patent Application No. 2011218173 (hide)

Owner Aragon Pharmaceuticals, Inc.

Inventors Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D.

Agent Spruson & Ferguson

Pub. Number AU-A-2011218173

PCT Pub. Number WO2011/103202

Priority 61/329,023 28.04.10 US; 61/388,457 30.09.10 US; 61/305,082 16.02.10 US

Filing date 16 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 31/4439

A61K 31/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61P 5/26 Drugs for disorders of the endocrine system

A61P 5/28 Drugs for disorders of the endocrine system

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

26 July 2012 PCT application entered the National Phase

  PCT publication WO2011/103202 Priority application(s): WO2011/103202

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218179-Method and device for non-invasive anatomical and systemic cooling and neuroprotection

2011218172-Internal communication system for a mobile robot